Fazpilodemab, CAS 2517935-02-1

Product Description: Fazpilodemab (BFKB8488A) is a humanized, agonistic, bispecific antibody targeting fibroblast growth factor receptor 1c (FGFR1c) and Klothoβ. Fazpilodemab can be used for the research of type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD)[1].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Wong C, et al. Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial. Hepatology. 2022 Aug 22.

CAS Number: 2517935-02-1

Molecular Weight: N/A

Compound Purity: 99.00

Research Area: Metabolic Disease

Solubility: H2O

Target: FGFR

• SKU: MEXHY-P99614-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99614-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated